GDF15 Recombinant Antibody: Enhance Your Research with Quality Solutions

If you're in search of a high-quality GDF15 recombinant antibody, you've come to the right place. I understand how crucial it is to have reliable tools for your research, and this antibody is specifically designed for precise and accurate results in various applications, Our GDF15 recombinant antibody is engineered to ensure optimal performance, making it ideal for both Western blotting and immunohistochemistry. With its exceptional specificity and sensitivity, it helps streamline your research workflow, allowing you to focus on advancing your projects, Alpha Lifetech Incorporation takes pride in delivering exceptional products that cater to your unique needs. We prioritize quality and reliability in every batch, backed by thorough validation processes. When you choose our GDF15 recombinant antibody, you’re not just purchasing a product; you’re investing in your success. Let's elevate your research together with tools that make a difference!

Hot Selling Product

ADT1332-J695 Biosimilar-Recombinant Human Monoclonal Antibody

ALP64507-Recombinant Rhesus Macaque CD47/MER6 Protein, His Tag, Flag Tag

ALP64508-Recombinant Human Siglec-10 Protein, Fc Tag

ALP64509-Recombinant Human Siglec-10 Protein, mFc Tag

ALP64514-Recombinant Human 5T4/TPBG Protein, Avi Tag, His Tag

ALP64516-Recombinant Human CD172a/SHPS-1/SIRPA Protein, His Tag

Best Way To Choose GDF15 recombinant antibody Global Reach Stands Out

Choosing the right GDF15 recombinant antibody is essential for researchers and pharmaceutical companies aiming to delve into the therapeutic potential of this Protein. With the increasing demand for high-quality antibodies, it’s crucial to consider specific factors when making this choice. Look for antibodies that have been validated in various applications, such as Western blotting, ELISA, or immunohistochemistry, to ensure their reliability and specificity in your experiments. Additionally, seeking antibodies that have demonstrated robust performance across different species can enhance their versatility in research applications. Another vital aspect is supplier credibility. Opt for suppliers with a proven track record in the field, particularly those with extensive experience in membrane protein production and monoclonal antibody development. Suppliers that offer detailed product information, including batch testing results and comprehensive customer support, will help ensure that your procurement aligns with your project requirements. Ensuring access to regional distribution can also facilitate timely delivery and support for your ongoing research. Lastly, consider the global reach of the supplier. A supplier with an international presence is more likely to offer diverse products and prompt customer service, no matter where you are located. This global outlook not only signifies reliability but also enhances your ability to access cutting-edge reagents like GDF15 recombinant antibodies, ultimately accelerating your research and development initiatives. By prioritizing these factors, you can make an informed and effective choice that drives your scientific goals forward.

Best Way To Choose GDF15 Recombinant Antibody Global Reach Stands Out

Antibody Name	Target Species	Reactivity	Application	Size (µg)	Price (USD)	Availability
GDF15 Rabbit Monoclonal Antibody	Human	High	Western Blot, ELISA	100	150.00	In Stock
GDF15 Mouse Monoclonal Antibody	Mouse	Medium	Immunohistochemistry	50	120.00	Pre-Order
GDF15 Goat Anti-Rabbit Antibody	Rabbit	High	ELISA, Western Blot	200	180.00	In Stock
GDF15 Polyclonal Antibody	Human, Mouse	High	Western Blot, IHC	500	250.00	In Stock

Analysis of GDF15 Recombinant Antibody Purchases by Region

The chart above illustrates the number of GDF15 recombinant antibody purchases across various global regions. North America leads with approximately 200 purchases, indicating a strong market presence and demand for this antibody in the biopharmaceutical sector. Following North America, Asia shows significant activity with 300 purchases, possibly due to an expanding biomedical research sector and growing investments in health and wellness. Europe comes next, with around 150 purchases, reflecting a steady interest in GDF15 for scientific research and clinical applications. South America and Oceania show lower numbers, with 100 and 75 purchases respectively, suggesting potential growth opportunities in these regions. Lastly, Africa shows the least activity with about 50 purchases, indicating challenges such as resource availability or awareness regarding GDF15 applications. This data highlights the varying global demand for GDF15 recombinant antibodies and suggests areas for targeted outreach and market expansion. Understanding these regional differences is crucial for stakeholders looking to optimize their strategies when introducing GDF15 recombinant antibodies to the market.